PerfWeb Special Series —Morning Session—Clinical and Financial Benefits of  Autotransfusion
PerfWeb Special Series —Morning Session—Clinical and Financial Benefits of Autotransfusion

PerfWeb Special Series —Morning Session—Clinical and Financial Benefits of Autotransfusion

  • Faculty: Hany Samir, MD, FCCP
  • Date: February 13th, 2020 9:00 am
  • CEU’s: 1.68 CEUs
  • Price: $25.2
  • Category 1 SDCE CEU
Buy Course
Course Rating:
(7 Reviews)

Latest Reviews

View All

Course description

This special program is designed for surgeons, anesthesia, perfusion, autotransfusion specialists, and nurses. 

Unlocking the Potential of Autotransfusion: A Comprehensive Guide to Enhancing Clinical Outcomes and Financial Efficiency

In the evolving landscape of healthcare, the quest for innovative practices that not only elevate patient care but also optimize operational efficiencies has never been more critical. Amid this pursuit lies the transformative practice of autotransfusion (AT), a technique that recycles a patient's own blood during surgery, offering a beacon of hope in bridging clinical excellence with financial prudence. This webinar delves deep into the multifaceted benefits of autotransfusion, elucidating its pivotal role in modern healthcare through a meticulous exploration of its clinical and financial advantages.

The Clinical Excellence of Autotransfusion

Autotransfusion stands out as a hallmark of patient-centered care, primarily due to its significant contributions to improving clinical outcomes. By reinfusing the patient's own blood, it circumvents the risks associated with allogeneic blood transfusions, such as transfusion-related immunomodulation (TRIM), transfusion-associated circulatory overload (TACO), and transfusion-related acute lung injury (TRALI). These complications, while rare, can have profound implications on patient recovery and mortality, making AT an invaluable asset in surgical settings.

Moreover, AT's role in reducing the exposure to blood-borne infections cannot be overstated. Despite stringent screening processes, the risk of transmitting infections through allogeneic transfusions, albeit minimal, remains a concern. Autotransfusion eliminates this risk, providing a safer alternative that enhances patient safety and peace of mind.

Another critical clinical advantage of AT is its contribution to preserving the patient's immune function. Allogeneic transfusions have been implicated in the modulation of the immune system, which can affect the patient's recovery and susceptibility to infections. Autotransfusion, by contrast, maintains the integrity of the patient's immune response, facilitating a smoother and potentially quicker recovery process.

The Financial Prudence of Autotransfusion

The financial implications of adopting autotransfusion are equally compelling, making a strong case for its integration into healthcare practices. One of the most immediate financial benefits is the reduction in the costs associated with acquiring, testing, and storing allogeneic blood. These savings are particularly significant given the increasing demand for blood products and the logistical and regulatory challenges associated with blood banking.

Moreover, autotransfusion contributes to a more efficient allocation of healthcare resources. By minimizing the need for allogeneic blood, hospitals can better manage their blood supply, prioritizing it for cases where autotransfusion is not feasible. This strategic resource allocation not only enhances operational efficiency but also supports broader healthcare sustainability efforts.

Beyond the direct cost savings, autotransfusion has a positive impact on the overall cost of patient care. The reduction in transfusion-related complications leads to shorter hospital stays and fewer readmissions, translating into substantial cost savings for healthcare facilities. Additionally, by improving clinical outcomes, AT contributes to a better quality of life for patients, potentially reducing long-term healthcare costs associated with post-surgical complications.

Implementing Autotransfusion: Challenges and Considerations

Despite its clear benefits, the implementation of autotransfusion is not without its challenges. The initial setup costs, including the acquisition of specialized equipment and training of personnel, can be significant. However, these costs are an investment in safer, more efficient care that pays dividends in the long run through improved patient outcomes and cost savings.

Another consideration is the clinical suitability of patients for autotransfusion. While AT is broadly applicable, certain patient conditions may necessitate careful evaluation to ensure the safety and efficacy of the procedure. Tailoring AT protocols to meet individual patient needs is essential for maximizing its benefits while minimizing risks.

The Future of Autotransfusion in Healthcare

As healthcare continues to evolve, the role of autotransfusion is set to become increasingly prominent. Advances in technology and techniques are making AT more accessible and applicable to a broader range of surgical procedures. Furthermore, the growing emphasis on patient safety and healthcare efficiency underscores the value of practices like autotransfusion that align with these priorities.

To fully realize the potential of autotransfusion, ongoing research and education are crucial. Healthcare professionals must stay abreast of the latest developments in AT to optimize its application and outcomes. Additionally, educating patients about the benefits and options available through autotransfusion can empower them to make informed decisions about their care.


Autotransfusion represents a nexus of clinical excellence and financial prudence, offering a forward-thinking approach to patient care that aligns with the imperatives of modern healthcare. By enhancing patient safety, improving clinical outcomes, and delivering cost savings, autotransfusion exemplifies the synergy between clinical innovation and operational efficiency. As healthcare systems worldwide strive to meet the dual challenges of delivering high-quality care and managing resources

The lecture portion will be presented by Dr. Hany Samir. 
Dr. Samir is a transplant anesthesiologist, intensivist and is passionate about transfusion management and positioning patients to need fewer transfusions or none at all. 
Dr. Samir will discuss the clinical and financial benefits of autotransfusion as part of a comprehensive transfusion management program.
#perfusion #criticalcare #autotransfusion 
Register and watch for free @ 
Get our Critical Care / Perfusion / ECMO App - 
IV Dosage and Rate Calculator - 

Meet Your Instructor

Hany Samir, MD, FCCP

Hany Samir, MD, FCCP

Dr. Hany Samir is the founder and CEO of HS Consulting for Telehealth, Assistant Professor of Cardiovascular Anesthesiology and Critical Care with Weill Cornell Medical College at the DeBakey Heart

Read Full Bio